Synopsys, Inc. (NASDAQ:SNPS) Given Average Recommendation of “Hold” by Analysts

Shares of Synopsys, Inc. (NASDAQ:SNPS) have earned an average recommendation of “Hold” from the eighteen brokerages that are covering the firm, Marketbeat reports. Four research analysts have rated the stock with a sell rating, five have given a hold rating and nine have issued a buy rating on the company. The average 12 month target price among analysts that have updated their coverage on the stock in the last year is $562.1429.

A number of equities research analysts recently weighed in on SNPS shares. Morgan Stanley cut their price objective on shares of Synopsys from $715.00 to $510.00 and set an “overweight” rating on the stock in a research note on Thursday, September 11th. Mizuho dropped their price target on shares of Synopsys from $700.00 to $600.00 and set an “outperform” rating on the stock in a research report on Thursday, September 11th. Rosenblatt Securities reiterated a “neutral” rating and issued a $605.00 price objective (down from $650.00) on shares of Synopsys in a report on Wednesday, September 10th. Stifel Nicolaus lowered their price objective on shares of Synopsys from $650.00 to $550.00 and set a “buy” rating on the stock in a research note on Wednesday, September 10th. Finally, Baird R W downgraded Synopsys from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, September 10th.

Synopsys Stock Performance

Shares of NASDAQ SNPS opened at $400.77 on Tuesday. Synopsys has a 12-month low of $365.74 and a 12-month high of $651.73. The company has a market cap of $74.44 billion, a PE ratio of 31.46, a P/E/G ratio of 5.02 and a beta of 1.10. The stock has a 50 day simple moving average of $471.09 and a 200-day simple moving average of $515.25. The company has a current ratio of 1.62, a quick ratio of 1.51 and a debt-to-equity ratio of 0.52.

Synopsys (NASDAQ:SNPS) last posted its earnings results on Tuesday, September 9th. The semiconductor company reported $2.30 EPS for the quarter, missing the consensus estimate of $3.75 by ($1.45). Synopsys had a net margin of 31.04% and a return on equity of 10.82%. The business had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.77 billion. During the same quarter in the prior year, the business earned $3.43 earnings per share. The firm’s revenue was up 14.0% compared to the same quarter last year. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. On average, equities research analysts forecast that Synopsys will post 10.64 EPS for the current year.

Insider Transactions at Synopsys

In other Synopsys news, CFO Shelagh Glaser sold 3,655 shares of the business’s stock in a transaction dated Friday, September 5th. The shares were sold at an average price of $609.77, for a total value of $2,228,709.35. Following the sale, the chief financial officer directly owned 15,317 shares in the company, valued at approximately $9,339,847.09. The trade was a 19.27% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Robert G. Painter acquired 350 shares of Synopsys stock in a transaction dated Thursday, September 11th. The shares were acquired at an average price of $425.44 per share, with a total value of $148,904.00. Following the transaction, the director owned 2,291 shares in the company, valued at approximately $974,683.04. This represents a 18.03% increase in their position. The disclosure for this purchase is available in the SEC filing. In the last three months, insiders have sold 30,894 shares of company stock worth $16,760,783. Corporate insiders own 0.62% of the company’s stock.

Institutional Trading of Synopsys

Several institutional investors and hedge funds have recently added to or reduced their stakes in SNPS. Vanguard Group Inc. grew its holdings in shares of Synopsys by 20.7% in the 3rd quarter. Vanguard Group Inc. now owns 18,181,185 shares of the semiconductor company’s stock worth $8,970,415,000 after acquiring an additional 3,120,401 shares during the last quarter. Norges Bank purchased a new stake in shares of Synopsys during the second quarter valued at $647,964,000. Nuveen LLC acquired a new position in shares of Synopsys in the 1st quarter valued at $341,480,000. Pictet Asset Management Holding SA increased its stake in Synopsys by 38.3% in the 1st quarter. Pictet Asset Management Holding SA now owns 2,432,596 shares of the semiconductor company’s stock worth $1,043,518,000 after purchasing an additional 673,837 shares in the last quarter. Finally, Ameriprise Financial Inc. raised its holdings in Synopsys by 29.1% during the 2nd quarter. Ameriprise Financial Inc. now owns 2,598,874 shares of the semiconductor company’s stock worth $1,333,095,000 after buying an additional 585,494 shares during the period. 85.47% of the stock is owned by institutional investors and hedge funds.

Synopsys Company Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.